Sanofi Toronto Facility Update Regarding ImmuCyst
date:Jul 12, 2012
s about the product. There is an authorized alternative available in Canada that treats bladder cancer.
Health Canada has already worked with Sanofi regarding its voluntary recall from the Canadian market of all Bacille Calmette-Guerin(BCG) tuberculosis vaccineproduced in the same building at its Toronto facility. The Public Health Agency of Canada is taking steps to secure an alternate supply of this vaccine.
In light of the manufacturing problems at the Toronto plant, there may be a global imp
3/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/19 11:14